Cannabinoids for the treatment of mental disorders [Carta] (2020)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; OSORIO, FLAVIA DE LIMA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP
- Unidade: FMRP
- DOI: 10.1016/S2215-0366(19)30516-4
- Subjects: CANABINOIDES; ARTIGO CIENTÍFICO
- Language: Inglês
- Imprenta:
- Source:
- Título: The Lancet Psychiatry
- ISSN: 2215-0366
- Volume/Número/Paginação/Ano: v. 7, n. 2, p. 125-126, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabinoids for the treatment of mental disorders [Carta]. The Lancet Psychiatry. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S2215-0366(19)30516-4. Acesso em: 05 out. 2024. , 2020 -
APA
Crippa, J. A. de S., Osório, F. de L., Hallak, J. E. C., Guimarães, F. S., & Zuardi, A. W. (2020). Cannabinoids for the treatment of mental disorders [Carta]. The Lancet Psychiatry. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/S2215-0366(19)30516-4 -
NLM
Crippa JA de S, Osório F de L, Hallak JEC, Guimarães FS, Zuardi AW. Cannabinoids for the treatment of mental disorders [Carta] [Internet]. The Lancet Psychiatry. 2020 ; 7( 2): 125-126.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/S2215-0366(19)30516-4 -
Vancouver
Crippa JA de S, Osório F de L, Hallak JEC, Guimarães FS, Zuardi AW. Cannabinoids for the treatment of mental disorders [Carta] [Internet]. The Lancet Psychiatry. 2020 ; 7( 2): 125-126.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/S2215-0366(19)30516-4 - Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
- Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]
- Effects of minocycline on regional cerebral blood flow in schizophrenia
- Canabidiol: possíveis aplicacões terapêuticas em psicopatologias
- A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
- Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia
- Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug
- Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
- Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
Informações sobre o DOI: 10.1016/S2215-0366(19)30516-4 (Fonte: oaDOI API)
Download do texto completo
Tipo | Nome | Link | |
---|---|---|---|
003016738.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas